Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid to reduce blood loss after CABG in clopidogrel-treated patients
IRCT201309125381N8Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in postoperative hemorrhage, sponsored by Babol University of Medical Sciences. Primary endpoint: Postoperative blood loss after CABG. Started Aug 2013; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on IRCT201309125381N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201309125381N8.